Sort
51,593 grants matching “hepatitis”
PROPHYLACTIC &THERPEUTIC DNA IMMUNIZATION AGAINST HCV
$496,980New York Blood Center · R01 · FY2001 · AI
Aldehydes in Alcohol-Induced Organ Injury
$496,868Zhanxiang Zhou · University Of North Carolina Greensboro · R01 · FY2010 · AA
Dissecting the NRG4 hormonal checkpoint in metabolic liver disease
$496,844Jiandie D Lin · University Of Michigan At Ann Arbor · R01 · FY2021 · DK
DAT-Emulating target trials with big data to strengthen the evidence base for the clinical management of opioid use disorder
$496,719Bohdan Nosyk · Simon Fraser University · R01 · FY2021 · DA
Development and application of non-thermal high frequency IRE to treat hepatic tumors
$496,695Rafael Vidal Davalos · Virginia Polytechnic Inst And St Univ · R01 · FY2022 · CA
Genetic Determinants of Weight Loss and Resolution of Co-Morbidities
$496,676Glenn S Gerhard · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2013 · DK
New methods for computational modeling of RNA structures
$496,674Shi-Jie Chen · University Of Missouri-Columbia · R35 · FY2024 · GM
New methods for computational modeling of RNA structures
$496,674Shi-Jie Chen · University Of Missouri-Columbia · R35 · FY2022 · GM
New methods for computational modeling of RNA structures
$496,674Shi-Jie Chen · University Of Missouri-Columbia · R35 · FY2023 · GM
New methods for computational modeling of RNA structures
$496,674Shi-Jie Chen · University Of Missouri-Columbia · R35 · FY2021 · GM
New broad-spectrum antivirals: target bunyaviruses
$496,672Hepadnavirus Testing, Inc. · R43 · FY2003 · AI
Host response and liver disease in a hepatitis C-like virus rat model
$496,663Amit Kapoor · Research Inst Nationwide Children'S Hosp · R01 · FY2020 · AI
North Texas Hepatitis B Consortium: Clinical Site for the Hepatitis B Network
$496,631William M Lee · Ut Southwestern Medical Center · U01 · FY2010 · DK
Developing Novel Ambroxol Analogs as Disease-Modifying Therapies for Alzheimer's Disease and Related Dementias
$496,600Robert Johnston · Zywie Llc · R43 · FY2025 · AG
The Development of TGR5 Antagonists for the Treatment of Cholangiopathies
$496,591Steven H Olson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · DK
Harnessing the power of peer navigation and mHealth to reduce health disparities in Appalachia
$496,556Scott D Rhodes · Wake Forest University Health Sciences · R01 · FY2020 · NR
LIFR-alpha/JAK/STAT3-dependent Adipose Inflammation Contributes to Obesity-Associated NAFLD - Resubmissi
$496,510Rodney E Infante · Ut Southwestern Medical Center · R01 · FY2024 · DK
Mechanism of Proteotoxicity and Experimental Therapeutic Approaches in Porphyria
$496,478M Bishr Omary · University Of Michigan At Ann Arbor · R01 · FY2018 · DK
DECONSTRUCTING INFLAMMATION AND ALTERED MICROBIOTA IN METABOLIC SYNDROME
$496,449Andrew T Gewirtz · Georgia State University · R01 · FY2022 · DK
JEOL 2100 LaB6 Transmission Electron Microscope with GATAN Ultrascan 1000 Camera
$496,375Paula Traktman · Medical College Of Wisconsin · S10 · FY2006 · RR
Growth Hormone Regulation of Sex Differences in Liver Metabolism
$496,343David J Waxman · Boston University (Charles River Campus) · R01 · FY2023 · DK
Arachidonate Products and CYP1A in Dioxin Toxicity
$496,341Arleen B. Rifkind · Weill Medical Coll Of Cornell Univ · R01 · FY2008 · ES
Mechanisms of NAT2 Regulation of Insulin Resistance and Mitochondrial Dysfunction
$496,339Joshua Wiley Knowles · Stanford University · R01 · FY2021 · DK
Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury
$496,295Mohan Kumar Krishnan · University Of Nebraska Medical Center · R01 · FY2023 · HL
Thrombocytopoiesis in Diabetes: Role of Damage Associated Molecular Patterns
$496,290Prabhakara Reddy Nagareddy · University Of Alabama At Birmingham · R01 · FY2018 · HL